Inclination Toward Digital Devices Fuels Asia Pacific Digital Thoracic Drainage Devices Market
The healthcare sector is keen on adopting medical devices enabled by digital technologies. The incorporation of IoT and artificial intelligence imparts capabilities such as real-time readings and health tracking into digital medical devices. Currently, the healthcare sector is rapidly adopting telecommunications devices in respiratory applications. Digital technologies in pulmonary function monitoring have been affirmed to provide significant and cost-effective results in home-care settings. An internet-based digital drainage system would help healthcare staff to monitor their patients’ health in the homecare settings, alongside enabling an early discharge of patients from hospitals, thus facilitating cost reduction. With these systems, healthcare providers can address all patient concerns remotely. However, a few of the notable risks associated with internet-based digital thoracic drainage devices include uncertainties related to the internet, leading to may create emergencies such as disconnection or malfunction of the device due to poor connectivity. Such shortcomings make taking intermediate steps, such as integrating good internet network with better connectivity and installing systems to notify the disparity in the readings provided by the digital thoracic systems before discharging patients essential. Irrespective of these limitations, internet-based digital thoracic drainage devices are expected to have a good possibility of acceptance in the thoracic telemedicine area, thereby providing notable growth opportunities to the Asia Pacific digital thoracic drainage devices market in the future.Asia Pacific Digital Thoracic Drainage Devices Market Overview
The Asia Pacific digital thoracic drainage devices market is segmented into China, Japan, India, South Korea, Australia and the Rest of Asia Pacific. The growth in the region is driven by an increase in respiratory disorders, rise in the number of surgeries performed, expansion of the healthcare sector, and increasing awareness about digital thoracic drainage devices. According to BioMed Central, China recorded over 40% of deaths due to cardiovascular disease (CVD) in 2022, and the number of CVD deaths has nearly doubled over the past two decades, in contrast to a drop in high-income nations. The prevalence of chronic diseases has also sharply increased in the nation in recent years. According to data released in February 2023 by the NCBI, 179.9 million Chinese older adults suffered from chronic conditions, such as diabetes, cancer, and heart disease. These and other chronic illnesses are the main contributors to healthcare costs and the major cause of death and disability in China. This has increased the need for thoracic drainage devices and improved their growth prospects.Asia Pacific Digital Thoracic Drainage Devices Market Revenue and Forecast to 2030 (US$ Million)
Asia Pacific Digital Thoracic Drainage Devices Market Segmentation
The Asia Pacific digital thoracic drainage devices market is segmented into product type, application, end user, and country.Based on product type, the Asia Pacific digital thoracic drainage devices market is segmented into single chamber and multiple chambers. The single chamber segment held a larger share of the Asia Pacific digital thoracic drainage devices market in 2022.
Based on application, the Asia Pacific digital thoracic drainage devices market is segmented into cardiac surgery, thoracic and pulmonary surgery, oncology and trauma, infectious diseases, and others. The thoracic and pulmonary surgery segment held the largest share of the Asia Pacific digital thoracic drainage devices market in 2022.
Based on end user, the Asia Pacific digital thoracic drainage devices market is segmented into hospitals, ambulatory surgical centers, and others. The hospitals segment held the largest share of the Asia Pacific digital thoracic drainage devices market in 2022.
Based on country, the Asia Pacific digital thoracic drainage devices market is segmented int o China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. China dominated the Asia Pacific digital thoracic drainage devices market in 2022.
ATMOS MedizinTechnik GmbH & Co KG, Cardinal Health Inc, Getinge AB, Medela AG, Pacific Hospital Supply Co Ltd, Redax SpA, Rocket Medical Plc, and Teleflex Inc are some of the leading companies operating in the Asia Pacific digital thoracic drainage devices market.
Table of Contents
Executive Summary
At 5.6% CAGR, the Asia Pacific Digital Thoracic Drainage Devices Market is speculated to be worth US$ 70.64 million by 2030.According to this research, the Asia Pacific digital thoracic drainage devices market was valued at US$ 45.53 million in 2022 and is expected to reach US$ 70.64 million by 2030, registering a CAGR of 5.6% from 2022 to 2030. Need for digital thoracic drainage post-thoracic surgery and advantages of digital thoracic drainage devices over analog thoracic drainage devices are among the critical factors attributed to the Asia Pacific digital thoracic drainage devices market expansion.
Digital thoracic drainage devices have several advantages over analog thoracic drainage devices. Digital thoracic drainage devices can accurately measure and monitor intrathoracic pressure changes and air leaks in real time. These devices allow objective and quantitative analyses that enable the management of patients having a prolonged, persistent air leak into the pleural space. Further, digital thoracic drainage devices have lightweight and compact designs that do not require connection to the wall suction, as they are incorporated with an integrated suction pump, enabling easy patient transfer from operating table to beds. These devices are powered by rechargeable batteries that run for at least 12 hours, and they are designed with special features of alarms that indicate situations such as tube occlusion, system disconnection, and suction failure.
Digital thoracic drainage devices eliminate variations possible in clinical judgment by providing information on air leaks, which can be objectively quantified and stored over time. Compared to analog or conventional thoracic drainage devices, digital drainage devices confer better safety for patients and healthcare providers. As these are completely closed systems, the fluid does not come in contact with the outside environment, nullifying the chances of infections among patients, as well as their spread to healthcare providers. Various advantages of digital thoracic drainage devices help surgeons determine the optimal timing of removing drainage devices, in turn, reducing the length of hospital stays for patients.
On the contrary, lack of skilled personnel hampers the Asia Pacific digital thoracic drainage devices market.
Based on product type, the Asia Pacific digital thoracic drainage devices market is segmented into single chamber and multiple chambers. The single chamber segment held 84.1% share of Asia Pacific digital thoracic drainage devices market in 2022, amassing US$ 38.30 million. It is projected to garner US$ 58.59 million by 2030 to expand at 5.5% CAGR during 2022-2030.
Based on application, the Asia Pacific digital thoracic drainage devices market is segmented into cardiac surgery, thoracic and pulmonary surgery, oncology and trauma, infectious diseases, and others. The thoracic and pulmonary surgery segment held 45.7% share of Asia Pacific digital thoracic drainage devices market in 2022, amassing US$ 20.81 million. It is projected to garner US$ 33.42 million by 2030 to expand at 6.1% CAGR during 2022-2030.
Based on end user, the Asia Pacific digital thoracic drainage devices market is segmented into hospitals, ambulatory surgical centers, and others. The hospitals segment held 48.8% share of Asia Pacific digital thoracic drainage devices market in 2022, amassing US$ 22.22 million. It is projected to garner US$ 35.67 million by 2030 to expand at 6.1% CAGR during 2022-2030.
Based on country, the Asia Pacific digital thoracic drainage devices market has been categorized into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. Our regional analysis states that China captured 30.1% share of Asia Pacific digital thoracic drainage devices market in 2022. It was assessed at US$ 13.69 million in 2022 and is likely to hit US$ 22.56 million by 2030, exhibiting a CAGR of 6.4% during 2022-2030.
Key players operating in the Asia Pacific digital thoracic drainage devices market are ATMOS MedizinTechnik GmbH & Co KG, Cardinal Health Inc, Getinge AB, Medela AG, Pacific Hospital Supply Co Ltd, Redax SpA, Rocket Medical Plc, and Teleflex Inc, among others.
Companies Mentioned
- ATMOS MedizinTechnik GmbH & Co KG
- Cardinal Health Inc
- Getinge AB
- Medela AG
- Pacific Hospital Supply Co Ltd
- Redax SpA
- Rocket Medical Plc
- Teleflex Inc
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 78 |
Published | December 2023 |
Forecast Period | 2022 - 2030 |
Estimated Market Value in 2022 | 45.53 Million |
Forecasted Market Value by 2030 | 70.64 Million |
Compound Annual Growth Rate | 5.6% |
Regions Covered | Asia Pacific |
No. of Companies Mentioned | 8 |